TATYANA VALENTIN: Open Payments
NPI 1659986735 · EASTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,692 in 91 payments from 26 companies in 2025. Trend: 2023 $768 · 2024 $1,387 · 2025 $1,692
Food & beverage: $1,692
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $244 |
| Teva Pharmaceuticals USA, Inc. | 12 | $187 |
| Novartis Pharmaceuticals Corporation | 14 | $183 |
| JAZZ PHARMACEUTICALS INC. | 5 | $121 |
| Lilly USA, LLC | 5 | $110 |
| PFIZER INC. | 4 | $79 |
| Axsome Therapeutics, Inc. | 3 | $77 |
| Amneal Pharmaceuticals LLC | 3 | $74 |
| EMD Serono, Inc. | 3 | $71 |
| Celgene Corporation | 4 | $65 |
Products named: AUSTEDO XR, KESIMPTA, QULIPTA, XYWAV, Sunosi, CREXONT, BOTOX, ZEPOSIA.
Industry payments across MD — which companies pay providers there.
